Patents by Inventor Guanglin Cui

Guanglin Cui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240138727
    Abstract: The present application is applicable to the technical field of muscle oxygen saturation detection, and provides a muscle oxygen saturation detection method, and a muscle oxygen saturation recovery method and system. The muscle oxygen saturation detection method is applied to a muscle oxygen saturation detection device. The present application combines pulse electrical stimulation for relieving the muscle fatigue and improving the muscle activity function with muscle oxygen saturation detection, and automatically triggers the turning-on and turning-off of electrical stimulation with the muscle oxygen saturation detection data of a wearer to form a closed-loop muscle function detection and stimulation system with feedback.
    Type: Application
    Filed: December 28, 2023
    Publication date: May 2, 2024
    Applicant: SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
    Inventors: Han CUI, Guanglin LI
  • Patent number: 10012654
    Abstract: The present invention provides a method of determining whether a patient with inflammatory bowel disease (IBD) and who has been treated with anti TNF? therapy is in immunological remission (IR), said method comprising determining the level of a cytokine selected from TNF?, IL-17 and IFN-y in a Gl mucosal sample from said patient. Also provided are methods of prognosis and treatment using said method of determination, in particular discontinuing treatment if said patient is in IR and continuing treatment if said patient is not in IR.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: July 3, 2018
    Assignee: UNIVERSITY OF TROMSØ
    Inventors: Jon Florholmen, Trine Olsen, Renathe Rismo, Rasmus Goll, Guanglin Cui
  • Publication number: 20150323546
    Abstract: The present invention provides a method of determining whether a patient with inflammatory bowel disease (IBD) and who has been treated with anti TNF? therapy is in immunological remission (IR), said method comprising determining the level of a cytokine selected from TNF?, IL-17 and IFN-? in a G1 mucosal sample from said patient. Also provided are methods of prognosis and treatment using said method of determination, in particular discontinuing treatment if said patient is in IR and continuing treatment if said patient is not in IR.
    Type: Application
    Filed: December 23, 2013
    Publication date: November 12, 2015
    Inventors: Jon Florholmen, Trine Olsen, Renathe Rismo, Rasmus Goll, Guanglin Cui